You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-HLA E antibody [MEM-E/02] (ab2216)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab2216? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab2216 has been referenced in 6 publications.

  1. Menier C et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 64:315-26 (2003). PubMed: 12590976
  2. Gooden M et al. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes. Proc Natl Acad Sci U S A 108:10656-61 (2011). IHC-P; Human. PubMed: 21670276
  3. Park B et al. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med : (2010). WB; Human. PubMed: 20713594
  4. de Kruijf EM et al. HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients. J Immunol 185:7452-9 (2010). IHC-P; Human. PubMed: 21057081
  5. Grotzke JE et al. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog 5:e1000374 (2009). WB; Human. PubMed: 19360129
  6. Götherström C et al. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 90:1017-26 (2005). PubMed: 16079100

Publishing research using ab2216? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"